Mitochondrial disorders are debilitating and life-threatening diseases that still lack effective treatment. They are due to genetic defects affecting oxidative phosphorylation, thus mitochondrial fitness and ATP production.
Patients with complex III dysfunction develop progressive neurological impairment, myopathy and meet an early death. Currently, no treatment for such pathologies exist.
We have developed a pharmaceutical strategy to “replace” the defective complex III. We found that redox cyclers (compounds undergoing reduction to form radical species that can then react with oxygen, thus regenerating the parent molecule), such as pyocyanin, can recover the mitochondrial function in patient-derived cells and ameliorate the pathological phenotypes animal models of complex III deficiency. Similar results were obtained in disease models linked to mitochondrial complex I dysfunction as well.
See also Peruzzo et al., Nat Commun (2021).

TRL 4 / 9

Inventors

Ildiko
Szabò

Roberta
Peruzzo

Mario
Zoratti

Rodolfo
Costa

Massimo
Zeviani

Download the brochure

  • A compound to mitigate the cytokine storm

    The body’s inflammatory response to fight infections and in tissue repair processes is crucial for normal functioning of the body. Yet, if not controlled, it can cause severe injury to the human body, as occurs during cytokine storm, a potentially[...]

  • Use of small molecules to rescue folding defective proteins

    The use of CFTR (cystic fibrosis transmembrane conductance regulator) correctors for the treatment of rare and devastating genetic muscular diseases, namely sarcoglycanopathies and Brody myopathy, is the object of this invention. Sarcoglycanopathies and Brody myopathy are rare inherited striated muscle[...]

  • New anti-tumoral approach: peptides targeting the hexokinase 2 protein

    Current antineoplastic treatments are not sufficient to cure cancer, in part due to lack efficacy and/or selectivity. Further, they often display significant side effects calling for new therapeutic approaches. The invention consists in the design, realization and administration of peptides[...]

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation